Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Explore which Dividend Aristocrats Etf Has The Lowest Fees and why cost matters for long-term growth. Use this guide to choose efficiently.
27,609 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A leaked Meta audio from an April 30 all-hands meeting signals a shift toward leveraging compute and internal output ...
Hewlett Packard Enterprise just blew past expectations with stronger revenue and profits, stoking the AI server rally...
The White House has nominated Brian Johnson to head the CFPB, aiming to steer consumer protection policy as leadershi...
Billionaire investor Bill Ackman points to SpaceX's durable cash-flow engines, highlighting a cornerstone of value as...
Investors are buzzing about a potential shift in how Rocket Lab does business. This article delves into what a SpaceX...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
Palantir is betting big on an AI-first future. This article breaks down the strategy, what it could mean for investor...
The Bank Policy Institute is weighing legal action against the OCC to challenge national trust charters for crypto an...
Bitcoin hovers under $70,000 as a decisive break could trigger a renewed leg lower toward the $60,000s, testing key s...
ZachXBT alleges insider control as LAB token scrutiny rises amid an investigation into AI Terminal's $6 billion FDV p...
Ethereum faces renewed selling pressure after a failed attempt to reclaim key resistance. As the week unfolds, trader...